CN219737266U - Noninvasive blood analysis equipment based on spectral analysis - Google Patents

Noninvasive blood analysis equipment based on spectral analysis Download PDF

Info

Publication number
CN219737266U
CN219737266U CN202321184358.5U CN202321184358U CN219737266U CN 219737266 U CN219737266 U CN 219737266U CN 202321184358 U CN202321184358 U CN 202321184358U CN 219737266 U CN219737266 U CN 219737266U
Authority
CN
China
Prior art keywords
mounting hole
circuit board
luminous tube
luminotron
light shield
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202321184358.5U
Other languages
Chinese (zh)
Inventor
王祥福
李家燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yunnan Celaifu Technology Co ltd
Original Assignee
Yunnan Celaifu Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yunnan Celaifu Technology Co ltd filed Critical Yunnan Celaifu Technology Co ltd
Priority to CN202321184358.5U priority Critical patent/CN219737266U/en
Application granted granted Critical
Publication of CN219737266U publication Critical patent/CN219737266U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

The utility model discloses noninvasive blood analysis equipment based on spectrum analysis, which relates to the technical field of blood analysis and specifically comprises a circuit board, wherein a light shield mounting seat is arranged at the top of the circuit board, a light shield is fixedly connected to the top of the light shield mounting seat, a detector mounting hole is formed in the center position of the light shield, a semiconductor spectrum detector is arranged in the detector mounting hole, and the semiconductor spectrum detector is connected with the circuit board; the utility model can noninvasively detect components in blood by being close to the surface of the skin of a patient, and effectively avoids the transmission of infectious diseases.

Description

Noninvasive blood analysis equipment based on spectral analysis
Technical Field
The utility model relates to the technical field of blood analysis, in particular to noninvasive blood analysis equipment based on spectrum analysis.
Background
At present, most blood routine detectors used in hospitals adopt a laser scattering mode, a blood sample plate is irradiated by laser, after the laser passes through the sample, the laser beam is scattered, the scattering rule of the laser beam is related to the components in the blood, and then the scattered laser is analyzed and counted to calculate and deduce the components in the blood. However, such methods of use necessarily require that a sufficient sample of the patient's blood be drawn. The cost of detection is not increased, and vein blood collection is needed for blood collection, if a patient has infectious diseases or bacteria exist in a blood collection environment, the risk of infection is not increased; of course, the conventional blood routine detector includes a photoelectric type, a capacitive type, a resistive type, and the like, in addition to the laser scattering type described above. But they all require that enough blood be collected from the patient to be analyzed.
As for blood glucose levels, it is not the case in conventional medical projects. The glucose oxidase is usually adopted to react with glucose in a blood sample, then a weak current is generated on an electrode of the blood glucose test paper, and after amplification and integral operation of an amplifier in the blood glucose meter, the content of glucose in blood can be estimated, namely the blood glucose value. Because the magnitude of the current generated by the reaction of glucose oxidase is proportional to the magnitude of the glucose concentration in blood, given a sufficient amount of glucose oxidase. Moreover, this reaction requires a trace amount of blood collection from the tip of the fingertip. However, even in the case of micro-blood collection, since invasive operations are required for the patient, any analysis of blood-related components has been conventionally performed only by performing invasive blood collection on the patient. Different methods and different detection items only differ in the amount of blood collected. To this end, we propose a non-invasive blood analysis device based on spectroscopic analysis.
Disclosure of Invention
The utility model provides non-invasive blood analysis equipment based on spectrum analysis, which solves the problem that the non-invasive blood analysis equipment can only be used for taking blood from a patient by an invasive way.
In order to achieve the above purpose, the utility model is realized by the following technical scheme:
the noninvasive blood analysis device based on spectrum analysis comprises a circuit board, wherein a light shield mounting seat is arranged at the top of the circuit board, a light shield is fixedly connected to the top of the light shield mounting seat, a detector mounting hole is formed in the center of the light shield, a semiconductor spectrum detector is arranged in the detector mounting hole, and the semiconductor spectrum detector is connected with the circuit board;
the light shield is provided with a plurality of positioning holes, the positioning holes are circumferentially distributed along the detector mounting holes, light emitting diodes are arranged in the positioning holes, the tops of the light emitting diodes are fixedly connected with optical filters, the light emitting diodes are connected with a circuit board, and one end of the circuit board is fixedly connected with a data connector.
Optionally, the positioning holes are a first light-emitting tube mounting hole, a second light-emitting tube mounting hole, a white light-emitting tube mounting hole, a third light-emitting tube mounting hole, a fourth light-emitting tube mounting hole, a fifth light-emitting tube mounting hole, a sixth light-emitting tube mounting hole and a seventh light-emitting tube mounting hole respectively;
390nm-400nm luminotrons are arranged in the first luminotron mounting hole, 425nm-430nm luminotrons are arranged in the second luminotron mounting hole, 495nm-500nm luminotrons are arranged in the third luminotron mounting hole, fourth luminotron mounting hole (620 nm-625nm luminotrons are arranged in the fifth luminotron mounting hole, 850nm luminotrons are arranged in the fifth luminotron mounting hole, 940nm luminotrons are arranged in the sixth luminotron mounting hole, and 1050nm luminotrons are arranged in the seventh luminotron mounting hole.
Optionally, the bottom fixedly connected with base of emitting diode, be connected with the luminotron pin on the base, luminotron pin and circuit board welding.
Optionally, a plurality of connecting blocks are connected on the outer wall of the light shield at equal intervals along the circumferential direction, and the connecting blocks are connected with the circuit board through bolts;
set up the fixed screw mounting hole on the connecting block, be equipped with the screw hole on the circuit board, the bolt runs through the fixed screw mounting hole and connects in the screw hole.
Optionally, the semiconductor spectrum detector comprises a transparent plastic shell, wherein a photosensitive chip is arranged in the transparent plastic shell, two sides of the photosensitive chip are connected with a plurality of chip pins, and the tail ends of the chip pins are welded with the circuit board.
The utility model has the following beneficial effects:
compared with the existing instrument, the noninvasive blood analysis equipment based on spectral analysis avoids the need of blood sampling to detect and analyze components in blood, and adopts the spectral analysis technology, and different subcutaneous tissues can be respectively measured through different spectral ranges, so that the spread of infectious diseases is avoided, and the risk of infection is effectively reduced.
Drawings
FIG. 1 is a schematic diagram of the structure of the present utility model;
FIG. 2 is a schematic diagram of a circuit board according to the present utility model;
FIG. 3 is a schematic view of a light shield according to the present utility model;
FIG. 4 is a schematic diagram of a light emitting diode according to the present utility model;
fig. 5 is a schematic structural diagram of a semiconductor spectrum detector of the present utility model.
In the figure: 1. a first light pipe mounting hole; 2. a set screw mounting hole; 3. a second luminous tube mounting hole; 4. a detector mounting hole; 5. a white multi-color light-emitting tube mounting hole; 6. a third luminous tube mounting hole; 7. a fourth luminous tube mounting hole; 8. a fifth luminous tube mounting hole; 9. a sixth luminous tube mounting hole; 10. a seventh luminous tube mounting hole; 11. a light shield mounting base; 12. screw holes; 13. a data connector; 14. a photosensitive wafer; 15. a transparent plastic housing; 16. chip pins; 17. a light filter; 18. a light emitting diode; 19. a base; 20. a luminous tube pin; 21. a light shield; 22. a circuit board; 23. and (5) connecting a block.
Detailed Description
The following description of the embodiments of the present utility model will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present utility model, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the utility model without making any inventive effort, are intended to be within the scope of the utility model.
Referring to fig. 1 to 5, the present utility model provides a technical solution:
the noninvasive blood analysis device based on spectrum analysis comprises a circuit board 22, wherein a light shield mounting seat 11 is arranged at the top of the circuit board 22, a light shield 21 is fixedly connected to the top of the light shield mounting seat 11, a detector mounting hole 4 is formed in the center position of the light shield 21, a semiconductor spectrum detector is arranged in the detector mounting hole 4, and the semiconductor spectrum detector is connected with the circuit board 22;
the light shield 21 is provided with 8 positioning holes, the positioning holes are distributed circumferentially along the detector mounting hole 4, the positioning holes are internally provided with light emitting diodes 18, the tops of the light emitting diodes 18 are fixedly connected with optical filters 17, the light emitting diodes 18 are connected with a circuit board 22, one end of the circuit board 22 is fixedly connected with a data connector 13, and the data connector 13 is used for reading out spectral data information.
The positioning holes are respectively a first luminous tube mounting hole 1, a second luminous tube mounting hole 3, a white shading luminous tube mounting hole 5, a third luminous tube mounting hole 6, a fourth luminous tube mounting hole 7, a fifth luminous tube mounting hole 8, a sixth luminous tube mounting hole 9 and a seventh luminous tube mounting hole 10;
390nm-400nm luminotrons are arranged in the first luminotron mounting hole 1, 425nm-430nm luminotrons are arranged in the second luminotron mounting hole 3, 495nm-500nm luminotrons are arranged in the third luminotron mounting hole 6, 620nm-625nm luminotrons are arranged in the fourth luminotron mounting hole 7, 850nm luminotrons are arranged in the fifth luminotron mounting hole 8, 940nm luminotrons are arranged in the sixth luminotron mounting hole 9, and 1050nm luminotrons are arranged in the seventh luminotron mounting hole 10.
During installation and manufacture, firstly, the light emitting diodes with the optical filters in the corresponding spectral ranges are respectively installed in corresponding installation holes, then, the semiconductor spectral detector is installed in the detector installation hole 4, all the parts are welded on the circuit board 22, and the light shield 21 is fixed on the circuit board 22 through bolts, so that the installation of the device can be completed;
the utility model is mainly used for roughly analyzing the components in the blood of a patient, can realize noninvasive analysis of the concentration of hemoglobin, the red blood cell count, the white blood cell count, the platelet count and the blood glucose value, does not need blood sampling in principle, breaks the situation that the existing instrument can only detect and analyze the components in the blood after blood sampling, adopts a spectrum analysis technology, and covers the ultraviolet, visible light, near infrared and middle infrared ranges in the spectrum range, and respectively measures different subcutaneous tissues in different spectrum ranges;
the ultraviolet range spectrum mainly detects the relevant thickness of epidermis and stratum corneum, including stratum corneum, stratum hyaline layer, granular layer, spiny layer and basal layer; the visible light spectrum mainly detects skin color and measures dermis information, including blood vessels and nerves in the dermis, and is used for post calculation and interference elimination; the near infrared light and mid infrared light spectrum analysis is adopted to measure the information of the fat layer and the fascia layer, so that the fat layer and the fascia layer can penetrate more than 10mm deep into subcutaneous tissues, and the components in blood can be effectively detected;
generating light in a specific spectral range by adopting a light emitting diode and an optical filter, directly entering human tissue from the surface of the skin by using light rays with specific spectrum, and then detecting light intensity by adopting a full-spectrum semiconductor detector at an adjacent position; the method adopts a spectrum analysis mode to noninvasively detect the hemoglobin concentration, the red blood cell count, the white blood cell count, the platelet count and the blood glucose value in blood, and can detect in real time, and the sampling interval is less than 5 minutes per sampling point.
The bottom of the light emitting diode 18 is fixedly connected with a base 19, a luminous tube pin 20 is connected to the base 19, and the luminous tube pin 20 is welded with a circuit board 22.
Wherein, a plurality of connecting blocks 23 are connected on the outer wall of the light shield 21 along the circumferential direction at equal intervals, and the connecting blocks 23 are connected with the circuit board 22 through bolts;
the connecting block 23 is provided with a fixing screw mounting hole 2, the circuit board 22 is provided with a screw hole 12, and a bolt penetrates through the fixing screw mounting hole 2 and is connected in the screw hole 12.
The semiconductor spectrum detector comprises a transparent plastic shell 15, wherein a photosensitive chip 14 is arranged in the transparent plastic shell 15, the photosensitive chip 14 is an OPT101 chip, two sides of the photosensitive chip 14 are connected with a plurality of chip pins 16, and the tail ends of the chip pins 16 are welded with a circuit board 22.
In summary, the non-invasive blood analysis device based on spectroscopic analysis needs to be worn at a predetermined location, usually including the inner side of an arm, or worn on the chest, and the like, before using the present utility model, and then the blood component information of the patient at this time, including the hemoglobin concentration, the red blood cell count, the white blood cell count, the platelet count, and the blood glucose value, is measured using a conventional blood conventional analyzer and a conventional blood glucose meter. Spectral data of epidermis and subcutaneous are then acquired by the present utility model simultaneously for comparison and calibration. After the calibration is completed, the method can be normally used.
The utility model then allows for non-invasive detection of components in the patient's blood, including hemoglobin concentration, red blood cell count, white blood cell count, platelet count, and blood glucose level, during the use phase. No venous blood sampling is required. Without the need of micro-blood collection at the tip of the fingertip. The utility model is only needed to be worn on the inner side of the arm to be clung to the skin or worn on the chest to be clung to the skin, but can not be used for the abdomen, because the utility model needs to be positioned at a place where the fat layer of the patient is thinner, the data acquisition and the data calculation can be more accurate. And the position worn during measurement must be kept consistent with the position worn during calibration learning. Otherwise a recalibration operation is required.
In the description of the present utility model, it should be noted that, directions or positional relationships indicated by terms such as "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer", etc., are based on directions or positional relationships shown in the drawings, are merely for convenience of description and simplification of description, and do not indicate or imply that the apparatus or element to be referred to must have a specific direction, be constructed and operated in the specific direction, and thus should not be construed as limiting the present utility model; the terms "first," "second," "third," and the like, are used for descriptive purposes only and are not to be construed as indicating or implying relative importance, and furthermore, unless explicitly specified and limited otherwise, the terms "mounted," "connected," "coupled," and the like are to be construed broadly, and may be fixedly coupled, detachably coupled, or integrally coupled, for example; can be mechanically or electrically connected; can be directly connected or indirectly connected through an intermediate medium, and can be communication between two elements. The specific meaning of the above terms in the present utility model will be understood in specific cases by those of ordinary skill in the art. Moreover, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
Although embodiments of the present utility model have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made therein without departing from the principles and spirit of the utility model, the scope of which is defined in the appended claims and their equivalents.

Claims (5)

1. A non-invasive blood analysis device based on spectroscopic analysis, comprising a circuit board (22), characterized in that: the top of the circuit board (22) is provided with a light shield mounting seat (11), the top of the light shield mounting seat (11) is fixedly connected with a light shield (21), a detector mounting hole (4) is formed in the center position of the light shield (21), a semiconductor spectrum detector is arranged in the detector mounting hole (4), and the semiconductor spectrum detector is connected with the circuit board (22);
the light shield (21) is provided with positioning holes, the number of the positioning holes is 8, the positioning holes are circumferentially distributed along the detector mounting holes (4), light emitting diodes (18) are arranged in the positioning holes, the tops of the light emitting diodes (18) are fixedly connected with optical filters (17), the light emitting diodes (18) are connected with a circuit board (22), and one end of the circuit board (22) is fixedly connected with a data connector (13).
2. A non-invasive blood analysis apparatus based on spectroscopic analysis according to claim 1, characterized in that: the positioning holes are respectively a first luminous tube mounting hole (1), a second luminous tube mounting hole (3), a white shading luminous tube mounting hole (5), a third luminous tube mounting hole (6), a fourth luminous tube mounting hole (7), a fifth luminous tube mounting hole (8), a sixth luminous tube mounting hole (9) and a seventh luminous tube mounting hole (10);
390nm-400nm luminotrons are arranged in the first luminotron mounting hole (1), 425nm-430nm luminotrons are arranged in the second luminotron mounting hole (3), 495nm-500nm luminotrons are arranged in the third luminotron mounting hole (6), 620nm-625nm luminotrons are arranged in the fourth luminotron mounting hole (7), 850nm luminotrons are arranged in the fifth luminotron mounting hole (8), 940nm luminotrons are arranged in the sixth luminotron mounting hole (9), and 1050nm luminotrons are arranged in the seventh luminotron mounting hole (10).
3. A non-invasive blood analysis apparatus based on spectroscopic analysis according to claim 1, characterized in that: the LED lamp is characterized in that a base (19) is fixedly connected to the bottom of the LED (18), a luminous tube pin (20) is connected to the base (19), and the luminous tube pin (20) is welded with a circuit board (22).
4. A non-invasive blood analysis apparatus based on spectroscopic analysis according to claim 1, characterized in that: a plurality of connecting blocks (23) are connected to the outer wall of the light shield (21) at equal intervals along the circumferential direction, and the connecting blocks (23) are connected with the circuit board (22) through bolts;
the connecting block (23) is provided with a fixed screw mounting hole (2), the circuit board (22) is provided with a screw hole (12), and a bolt penetrates through the fixed screw mounting hole (2) and is connected in the screw hole (12).
5. A non-invasive blood analysis apparatus based on spectroscopic analysis according to claim 1, characterized in that: the semiconductor spectrum detector comprises a transparent plastic shell (15), wherein a photosensitive chip (14) is arranged in the transparent plastic shell (15), two sides of the photosensitive chip (14) are connected with a plurality of chip pins (16), and the tail ends of the chip pins (16) are welded with a circuit board (22).
CN202321184358.5U 2023-05-17 2023-05-17 Noninvasive blood analysis equipment based on spectral analysis Active CN219737266U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202321184358.5U CN219737266U (en) 2023-05-17 2023-05-17 Noninvasive blood analysis equipment based on spectral analysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202321184358.5U CN219737266U (en) 2023-05-17 2023-05-17 Noninvasive blood analysis equipment based on spectral analysis

Publications (1)

Publication Number Publication Date
CN219737266U true CN219737266U (en) 2023-09-22

Family

ID=88026193

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202321184358.5U Active CN219737266U (en) 2023-05-17 2023-05-17 Noninvasive blood analysis equipment based on spectral analysis

Country Status (1)

Country Link
CN (1) CN219737266U (en)

Similar Documents

Publication Publication Date Title
US8133176B2 (en) Method and circuit for indicating quality and accuracy of physiological measurements
CN105307568B (en) non-invasive blood analysis
US11147482B2 (en) Method and system for non-invasive blood glucose measurement using signal change of the non-glucose components induced by the presence of glucose
WO2016036985A1 (en) Total hemoglobin index system
US20080200780A1 (en) Optical measurement of cellular energetics
WO2007144880A2 (en) System and method for measurement of biological parameters of a subject
US20070265513A1 (en) Optical measurement of mitochondrial function in blood perfused tissue
US20210059582A1 (en) Non-Invasive Glucose Monitoring by Raman Spectroscopy
CN104224159A (en) Device for detecting microcirculation blood flow on body surface of acupuncture point
CN109009064A (en) A kind of intracranial pressure noninvasive monitoring device and method
CN112261904A (en) Method of selecting intensity of light source for monitoring analyte in blood and apparatus therefor
Nirupa et al. Non-invasive measurement of hemoglobin content in blood
US20150223736A1 (en) System & method for determining blood component concentration
CN111698943A (en) Systems and methods for non-invasively monitoring hematocrit concentration
KR102326557B1 (en) System and Method for calculating pulse transit time for measuring glucose concentration value Using Multi-site PPGs at wrist
CN219737266U (en) Noninvasive blood analysis equipment based on spectral analysis
CN110575182A (en) Method and device for detecting blood sugar
WO2012178064A2 (en) System and method for detecting vascular contamination by surgical anesthetic using non-invasive ir spectrophotometry
JP2019198547A (en) Blood component measurement method, device and program
CN209450518U (en) A kind of intracranial pressure noninvasive monitoring device
CN116625961A (en) Noninvasive blood analysis equipment based on spectral analysis
CN111493887B (en) Handheld tubular biological probe and detection method for detecting activity of organs
Céelleri et al. Non-Invasive Blood Sugar Measurement System
CN113729700A (en) Noninvasive blood glucose detection device
WO2022012871A1 (en) Device for obtaining an indicator of a microcirculatory condition

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant